Immunization Archives - Infectious Disease Advisor


Investigational Vaccine to Prevent RSV in Older Patients Gets Breakthrough Status

Janssen announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for their investigational prophylactic vaccine for the prevention of respiratory syncytial virus (RSV)-mediated lower respiratory tract disease in adults aged 60 years and older. RSV is a highly prevalent and contagious respiratory infection. It is the most common cause of bronchitis…

Next post in Clinical Charts